SynthesisMedicine2016

Rituximab shows no effect on remission in patients with refractory nephrotic syndrome: A MOOSE-compliant meta-analysis.

Supei Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.